Jennifer Chien
Corporate Officer/Principal bei RHYTHM PHARMACEUTICALS, INC.
Vermögen: 261 404 $ am 30.04.2024
Aktive Positionen von Jennifer Chien
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 09.11.2020 | - |
Karriereverlauf von Jennifer Chien
Ehemalige bekannte Positionen von Jennifer Chien
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| KRYSTAL BIOTECH, INC. | Corporate Officer/Principal | 20.01.2020 | 16.10.2020 |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | 01.11.2014 | 01.01.2020 |
Ausbildung von Jennifer Chien
| Massachusetts Institute of Technology | Undergraduate Degree |
| Harvard University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
| Vereinigtes Königreich | 2 |
Operativ
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Finance | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| KRYSTAL BIOTECH, INC. | Health Technology |
| RHYTHM PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
- Börse
- Insiders
- Jennifer Chien
- Erfahrung
